SAARUM SCIENCES PRIVATE LIMITED, founded in 2012, is an emerging biotech firm specializing in Drug Discovery Platforms & Services. The company’s innovative approach integrates human tissues and cancer cells to explore disease biology, develop novel biomarkers, and discover new drug targets and therapeutics aimed at improving clinical outcomes.
Based in India and incubated at the Indian Institute of Chemical Technologies in Hyderabad, Saarum Sciences collaborates with Apollo Hospitals, India’s largest hospital network. This collaboration supports their original research in oncology and diseases of the central nervous system. Despite being in its nascent stage, the startup boasts three founder-scientists with over 60 years of international expertise in human disease biology and drug discovery.
Currently self-funded, Saarum Sciences presents a unique opportunity for investors interested in cutting-edge biotech ventures with significant potential for advancement in drug discovery and diagnostics.